Key result
In a rat model of myocardial infarction, knockdown of miR-134-5p alleviated adverse myocardial remodeling, manifesting as reduced cardiomyocyte hypertrophy and fibrosis.
Why the study?
Adverse myocardial remodeling manifests as hypertrophy and fibrosis after myocardial infarction and leads to cardiac dysfunction, but the underlying pathological mechanisms remain to be clarified.
Knockdown of miR-134-5p attenuates adverse myocardial remodeling after MI by reducing ROS accumulation driven by epicardial adipose tissue secretory products.
Answers are grounded in this paper and cite their sources.
EAT weight correlated with post-MI remodeling in rats; leaves open whether EAT modulation alters human outcomes.
Adverse myocardial remodeling, manifesting pathologically as myocardial hypertrophy and fibrosis, often follows myocardial infarction (MI) and results in cardiac dysfunction. In this study, an obvious epicardial adipose tissue (EAT) was observed in the rat model of MI and the EAT weights were positively correlated with cardiomyocyte size and myocardial fibrosis areas in the MI 2- and 4-week groups. Then, rat cardiomyocyte cell line H9C2 and primary rat cardiac fibroblasts were cultured in conditioned media generated from EAT of rats in the MI 4-week group (EAT-CM). Functionally, EAT-CM enlarged the cell surface area of H9C2 cells and reinforced cardiac fibroblast activation into myofibroblasts by elevating intracellular reactive oxygen species (ROS) levels. Mechanistically, miR-134-5p was upregulated by EAT-CM in both H9C2 cells and primary rat cardiac fibroblasts. miR-134-5p knockdown promoted histone H3K14 acetylation of manganese superoxide dismutase and catalase by upregulating lysine acetyltransferase 7 expression, thereby decreasing ROS level. An in vivo study showed that miR-134-5p knockdown limited adverse myocardial remodeling in the rat model of MI, manifesting as alleviation of cardiomyocyte hypertrophy and fibrosis. In general, our study clarified a new pathological mechanism involving an EAT/miRNA axis that explains the adverse myocardial remodeling occurring after MI.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2021) studied Myocardial infarction (n=78). AAV-sh-miR-134-5p vs. AAV-NC was evaluated on Adverse myocardial remodeling (cardiomyocyte hypertrophy and fibrosis) (p=<0.05). In a rat model of myocardial infarction, knockdown of miR-134-5p alleviated adverse myocardial remodeling, manifesting as reduced cardiomyocyte hypertrophy and fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: